BioNTech’s investment provides a template for UK growth, say ABPI
The innovative biopharmaceutical company BioNTech has announced a major investment of up to £1bn over 10 years in the UK, potentially creating more than 400 new jobs in London and Cambridge.
Read the full articleYou might also wanna read
Alchemab Therapeutics extends Series A with £25m investment
Alchemab Therapeutics has extended its Series A financing with £25m from the British Business Bank, marking the Bank’s largest investment in

Alchemab Therapeutics secures €29.3 million as British Business Bank makes its largest life sciences investment yet
Alchemab Therapeutics, a London-based clinical-stage BioTech startup, has extended its Series A financing with €29.3 million (£25 million/$3
Germany’s Merck Pumps Up Life Sciences Biz with $11.3B Bio-Techne Deal
Merck KGaA's agreement to buy Bio-Techne for $11.3 billion strengthens its hold in life sciences, especially drug discovery and gene therapy
Life sciences pulled in over £3bn since since sector plan launched
The UK life sciences sector has attracted more than £3bn in new public-private investment in the past 12 months, marking the first year of a

Cancer Research UK bets on Manchester with £6-million funding boost
Nature, Published online: 01 July 2026; doi:10.1038/d41586-026-02019-0 The investment provides a ‘special opportunity’ to establish the Canc
UK Quantum Biomedical Hub Awarded £902,000 for Clinical Sensing and Imaging Hardware Development
The UK National Quantum Biomedical Research Hub (Q-BIOMED) has been awarded £902,000 ($1.2 million USD) from the Engineering and Physical Sc

Comments
Sign in to join the conversation.
No comments yet. Be the first.